Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Cossarini

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Cureus|April 5, 2018
Extra Oxygen Leads to Bubble Trouble: Portal Vein Gas Embolism from 3% Hydrogen Peroxide IngestionJoowhan Sung, Francesca Cossarini, Leonidas Palaiodimos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2010
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infectionAntonella Castagna, Francesca Cossarini, Vincenzo Spagnuolo, et al.
AIDS Research and Human Retroviruses|July 14, 2023
Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV CureFrancesca Cossarini, Judith A Aberg, Benjamin K Chen, et al.
The New Microbiologica|February 26, 2013
Management of HIV infection after triple class failureFrancesca Cossarini, Vincenzo Spagnuolo, Nicola Gianotti, et al.
The American Journal of Medicine|November 24, 2015
The ReplyAnand Kumthekar, Francesca Cossarini, Julia C Shih, et al.
The American Journal of Medicine|February 10, 2015
Ranolazine-induced Repolarization Changes: A Case ReportAnand Kumthekar, Francesca Cossarini, Julia C Shih, et al.
Antiviral Therapy|February 2, 2012
Mortality of HIV-infected patients with or without cancer: comparison with the general population in ItalyLaura Galli, Vincenzo Spagnuolo, Stefania Salpietro, et al.
AIDS and Behavior|May 26, 2018
Missed Opportunities for HIV Prevention: Individuals Who HIV Seroconverted Despite Accessing HealthcareFrancesca Cossarini, David B Hanna, Mindy S Ginsberg, et al.
The Journal of Infectious Diseases|October 11, 2011
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravirFilippo Canducci, Elisa R Ceresola, Enzo Boeri, et al.
Cancer|April 30, 2013
Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort studyVincenzo Spagnuolo, Giovanna Travi, Laura Galli, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cureus|April 5, 2018
Extra Oxygen Leads to Bubble Trouble: Portal Vein Gas Embolism from 3% Hydrogen Peroxide IngestionJoowhan Sung, Francesca Cossarini, Leonidas Palaiodimos, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2010
Prior therapy influences the efficacy of lamivudine monotherapy in patients with lamivudine-resistant HIV-1 infectionAntonella Castagna, Francesca Cossarini, Vincenzo Spagnuolo, et al.
AIDS Research and Human Retroviruses|July 14, 2023
Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV CureFrancesca Cossarini, Judith A Aberg, Benjamin K Chen, et al.
The New Microbiologica|February 26, 2013
Management of HIV infection after triple class failureFrancesca Cossarini, Vincenzo Spagnuolo, Nicola Gianotti, et al.
The American Journal of Medicine|November 24, 2015
The ReplyAnand Kumthekar, Francesca Cossarini, Julia C Shih, et al.
The American Journal of Medicine|February 10, 2015
Ranolazine-induced Repolarization Changes: A Case ReportAnand Kumthekar, Francesca Cossarini, Julia C Shih, et al.
Antiviral Therapy|February 2, 2012
Mortality of HIV-infected patients with or without cancer: comparison with the general population in ItalyLaura Galli, Vincenzo Spagnuolo, Stefania Salpietro, et al.
AIDS and Behavior|May 26, 2018
Missed Opportunities for HIV Prevention: Individuals Who HIV Seroconverted Despite Accessing HealthcareFrancesca Cossarini, David B Hanna, Mindy S Ginsberg, et al.
The Journal of Infectious Diseases|October 11, 2011
Cross-resistance profile of the novel integrase inhibitor Dolutegravir (S/GSK1349572) using clonal viral variants selected in patients failing raltegravirFilippo Canducci, Elisa R Ceresola, Enzo Boeri, et al.
Cancer|April 30, 2013
Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort studyVincenzo Spagnuolo, Giovanna Travi, Laura Galli, et al.
Pageof 4